Management Team | Science Advisory Board

Leadership Team

Matthew Klipstein: Founder and CEO

Mr. Klipstein graduated with Honors from the University of California at Berkeley and from the University of Colorado School of Law.

Following law school, Mr. Klipstein was a Law Clerk to The Hon. Hatfield Chilson, United States District Judge, District of Colorado. Thereafter, he returned to San Francisco where he was co-founder and a partner in the law firm of Wolfe & Klipstein. At the age of 34, Mr. Klipstein retired from the practice of law and co-founded Digital Stock, Inc. a pioneer and industry leader in digital storage and distribution of high quality stock photography. Five years later Digital Stock was acquired by Bill Gates’ Corbis Corporation. Mr. Klipstein founded Neurorepair, Inc. in 2004.


James Fallon, Ph.D.: Chief Science Officer

Dr. Fallon is Professor Emeritus of Anatomy and Neurobiology at the University of California, Irvine. He is a Sloan and NIH RCDA Research Scholar and holds Doctoris Honoris and Research Excellence and Teaching Awards from multiple institutions. He is a Senior Research  Fulbright Fellow. He has been elected President of the UC Irvine Faculty and Chair of the Medical School faculty and is the developer of numerous novel medical and research training models.

Dr. Fallon discovered a characterized growth factor in the mammalian
brain (1984) and was first to demonstrate how to mobilize significant
numbers of adult stem cells and progenitors in the injured brain (1997, 2000), a unique finding highlighted in the NIH Stem Cell report to Congress.

His lab localized EGF, TGFα, and bFGF in the brain. He has written broadly on schizophrenia, addiction, and the basal ganglia, limbic system, and cortex. He was the neuroanatomist on the team that discovered the presence of extensive postnatal development of new neurons in the human brain, a discovery that was noted as one of the most startling and important findings during the decade of the brain.

Dr. Fallon carried out his doctoral training in Neuroanatomy and Neurophysiology at the University of Illinois and his postdoctoral training at the University of California, San Diego.


Darius Gleason, Ph.D.

Dr. Gleason received his Ph.D. from the University of California Irvine where he studied neural stem cell identity in the laboratories of Peter J. Bryant and James H. Fallon. Dr. Gleason was also a California Institute for Regenerative Medicine Fellow from 2006 to 2009.

In 2008 his work with Transforming Growth Factor alpha (TGFα) in a model of Parkinson’s disease led to the landmark finding that ependymal cells in the adult brain can be stimulated to divide and to contribute rapidly dividing daughter cells into the subventricular zone.

Dr. Gleason received a Young Investigator Award for this work at the NSCs and Regeneration Biosymposia in Boston. Dr. Gleason has also studied the therapeutic potential of TGFα in a model of stroke and found that, similar to the Parkinson’s disease model, treatment of even chronic stroke injuries with TGFα induces massive proliferation, migration and differentiation of adult neural stem cells and progenitors. Dr. Gleason also has a JD from the University of Southern California.


Science Advisory Board

The SAB currently includes James Fallon, Ph.D., Dr. Jay Short, and Dr. Steven Potkin.

Back to top

 

Matthew Klipstein
Matthew Klipstein, CEO

 

 

 

James Fallon, Ph.D.
James Fallon, Ph.D.

 

 

James Fallon, Ph.D.
Darius Gleason, Ph.D.